Akero Therapeutics Inc (AKRO)

06:40 AM

Possible Bearish Signals With Akero Therapeutics Insiders Disposing Stock - simplywall.st

06:40 AM

Mar 30, 2025

Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 6.3%Time to Sell? - MarketBeat

Mar 30, 2025

Mar 30, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com

Mar 30, 2025

Mar 30, 2025

Proficio Capital Partners LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Akero Therapeutics (NASDAQ:AKRO) Shares Gap Up Following Insider Buying Activity - MarketBeat

Mar 29, 2025

Mar 29, 2025

How To Trade (AKRO) - news.stocktradersdaily.com

Mar 29, 2025

Mar 28, 2025

G. Walmsley Graham Acquires 50,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat

Mar 28, 2025

Mar 28, 2025

Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Mar 28, 2025

Mar 28, 2025

Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing - MarketScreener

Mar 28, 2025

Mar 28, 2025

Simplify Asset Management Inc. Sells 19,089 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 28, 2025

Mar 28, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Acquired by Swiss National Bank - Defense World

Mar 28, 2025

Mar 27, 2025

Akero Therapeutics director Graham Walmsley buys $8.79m in stock By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Akero Therapeutics director Graham Walmsley buys $8.79m in stock - Investing.com India

Mar 27, 2025

Mar 27, 2025

Akero Therapeutics (AKRO) Stock Price, News & Analysis - MarketBeat

Mar 27, 2025

Mar 27, 2025

Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 27, 2025

Mar 26, 2025

Proficio Capital Partners LLC Invests $320,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Mar 26, 2025

Mar 26, 2025

Intech Investment Management LLC Buys 20,795 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 26, 2025

Mar 25, 2025

Yiheng Capital Management L.P. Sells 92,624 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 25, 2025

Mar 25, 2025

There is no way Akero Therapeutics Inc (AKRO) can keep these numbers up - SETE News

Mar 25, 2025

Mar 25, 2025

Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 25, 2025

Mar 25, 2025

Alumis and Kaken sign agreement in Japan for ESK-001 - Pharmaceutical Technology

Mar 25, 2025

Mar 24, 2025

Charles Schwab Investment Management Inc. Acquires 8,096 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 24, 2025

Mar 24, 2025

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands - Bluefield Daily Telegraph

Mar 24, 2025

Mar 24, 2025

Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire

Mar 24, 2025

Mar 24, 2025

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView

Mar 24, 2025

Mar 24, 2025

Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World

Mar 24, 2025

Mar 23, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Investors to Connect - Markets Insider

Mar 23, 2025

Mar 23, 2025

Kennondale Capital Management LLC Acquires New Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 23, 2025

Mar 23, 2025

Catriona Yale Sells 10,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat

Mar 23, 2025

Mar 21, 2025

10 Health Care Stocks Whale Activity In Today's Session - Benzinga

Mar 21, 2025

Mar 21, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Position Raised by Charles Schwab Investment Management Inc. - Defense World

Mar 21, 2025

Mar 21, 2025

Bank of New York Mellon Corp Sells 6,414 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Mar 21, 2025

Mar 20, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Markets Insider

Mar 20, 2025

Mar 20, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by AlphaQuest LLC - MarketBeat

Mar 20, 2025

Mar 19, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Sells 1,738 Shares of Stock - MarketBeat

Mar 19, 2025

Mar 18, 2025

How to Take Advantage of moves in (AKRO) - Stock Traders Daily

Mar 18, 2025

Mar 18, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $27,556.32 in Stock - MarketBeat

Mar 18, 2025

Mar 18, 2025

Akero therapeutics chief development officer sells $447,605 in stock By Investing.com - Investing.com Australia

Mar 18, 2025

Mar 18, 2025

Akero therapeutics chief development officer sells $447,605 in stock - Investing.com India

Mar 18, 2025

Mar 18, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells $27,242.16 in Stock - MarketBeat

Mar 18, 2025

Mar 18, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO William Richard White Sells 676 Shares - MarketBeat

Mar 18, 2025

Mar 17, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat

Mar 17, 2025